97 related articles for article (PubMed ID: 22859394)
1. Prognostic and predictive significance of proliferation in 867 colorectal cancers.
Fodor IK; Hutchins GG; Espiritu C; Quirke P; Jubb AM
J Clin Pathol; 2012 Nov; 65(11):989-95. PubMed ID: 22859394
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
3. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
5. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of CADM4 expression, and its correlation with expression of E-cadherin and Ki-67 in colorectal adenocarcinomas.
Jang SM; Han H; Jun YJ; Jang SH; Min KW; Sim J; Ahn HI; Lee KH; Jang KS; Paik SS
J Clin Pathol; 2012 Oct; 65(10):902-6. PubMed ID: 22718847
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
11. Lack of prognostic significance of conventional peritoneal cytology in colorectal and gastric cancers: results of EVOCAPE 2 multicentre prospective study.
Cotte E; Peyrat P; Piaton E; Chapuis F; Rivoire M; Glehen O; Arvieux C; Mabrut JY; Chipponi J; Gilly FN;
Eur J Surg Oncol; 2013 Jul; 39(7):707-14. PubMed ID: 23601984
[TBL] [Abstract][Full Text] [Related]
12. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
Dawson H; Koelzer VH; Karamitopoulou E; Economou M; Hammer C; Muller DE; Lugli A; Zlobec I
Histopathology; 2014 Mar; 64(4):577-84. PubMed ID: 24111856
[TBL] [Abstract][Full Text] [Related]
13. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer.
Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K
Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
16. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma.
Bhatavdekar JM; Patel DD; Chikhlikar PR; Shah NG; Vora HH; Ghosh N; Trivedi TI
Dis Colon Rectum; 2001 Apr; 44(4):523-33. PubMed ID: 11330579
[TBL] [Abstract][Full Text] [Related]
17. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
18. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
[TBL] [Abstract][Full Text] [Related]
19. Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
Li P; Xiao ZT; Braciak TA; Ou QJ; Chen G; Oduncu FS
Oncol Res Treat; 2016; 39(11):696-702. PubMed ID: 27855388
[TBL] [Abstract][Full Text] [Related]
20. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
